| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1996;62:1051-1058
© 1996 The Society of Thoracic Surgeons
Divisions of Cardiac Surgery and Cardiology and Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
Background. Transmyocardial revascularization reduces the symptoms and morbidity of patients with end-stage ischemic heart disease. The mechanism is postulated to be the formation of transmural left ventricular channels through which oxygenated blood directly perfuses the myocardium. New techniques for molecular enhancement of angiogenesis and endothelial cell motility may represent strategies to augment this clinical benefit.
Methods. Triads of transmyocardial revascularization channels were placed in eight separate nonischemic sites on the hearts of 7 pigs weighing 68 to 78 kg, which were allowed to recover and were then sacrificed at 28 days. In addition, one triad pair was injected with vascular endothelial growth factor, and two triad pairs received an adenovirus vector with or without the gene encoding for human profilin, which increases endothelial cell motility and adhesion. The remaining triad pair stood untreated (laser only). The histologic changes were graded (0 through 3) by an independent pathologist without knowledge of the treatment modality. Profilin production and vascular endothelial growth factor activation using a tyrosine kinase assay were monitored.
Results. Transmyocardial revascularization alone resulted in a significant injury response (p < 0.01), including increased vascularity without patent channels. Vascular endothelial growth factor increased surrounding inflammation (p < 0.01) without improving vascularity or patency. Profilin content in tissues was increased but nonspecifically because inflammation resulting from adenovirus also induces higher profilin concentrations.
Conclusions. The clinical benefit of transmyocardial revascularization may result simply from a nonspecific histologic response to injury. Molecular interventions appear to stimulate more inflammation but no additional angiogenesis. Further improvement in the clinical benefit of transmyocardial revascularization awaits the successful stimulation of a true angiogenic response.
Related Article
Ann. Thorac. Surg. 1996 62: 1058.
This article has been cited by other articles:
|
|
 |
|
  R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text]
|
|
|
|
|
|
K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text]
|
|
|
|
 |
|
 C. R. Bridges, K. A. Horvath, W. C. Nugent, D. M. Shahian, C. K. Haan, R. J. Shemin, K. B. Allen, and F. H. Edwards The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization Ann. Thorac. Surg., April 1, 2004; 77(4): 1494 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Saririan and M. J. Eisenberg Myocardial laser revascularization for the treatment of end-stage coronary artery disease J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A.U. Heilmann, T. Attmann, P. von Samson, H. Gobel, D. Marme, F. Beyersdorf, and G. Lutter Transmyocardial laser revascularization combined with vascular endothelial growth factor121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up? Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 74 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Schoen and R. F. Padera Jr. Cardiac Surgical Pathology Card. Surg. Adult, January 1, 2003; 2(2003): 119 - 185. [Full Text]
|
|
|
|
|
|
M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text]
|
|
|
|
 |
|
 A. Tandar, G.M. Saperia, and D.H. Spodick Direct myocardial revascularization and therapeutic angiogenesis Eur. Heart J., October 1, 2002; 23(19): 1492 - 1502. [Full Text] [PDF]
|
|
|
|
|
|
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert 35 years of experimental research in transmyocardial revascularization: what have we learned? Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Laham, M. Simons, J. D. Pearlman, K. K. L. Ho, and D. S. Baim Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization J. Am. Coll. Cardiol., January 2, 2002; 39(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Arora, G. M. Hirsch, K. Hirsch, and J. A. Armour Transmyocardial Laser Revascularization Remodels the Intrinsic Cardiac Nervous System in a Chronic Setting Circulation, September 18, 2001; 104(90001): I-115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Hamawy, L. Y. Lee, S. A. Samy, D. R. Polce, M. Szulc, M. Vazquez, and T. K. Rosengart Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density Ann. Thorac. Surg., September 1, 2001; 72(3): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Martin, U. Sayeed-Shah, J. G. Byrne, M. H.D. Danton, K. Q. Flores, R. G. Laurence, and L. H. Cohn Excimer versus carbon dioxide transmyocardial laser revascularization: effects on regional left ventricular function and perfusion Ann. Thorac. Surg., June 1, 2000; 69(6): 1811 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Y. Chiang, A. M. Roberts, A. M. Kashem, W. P. Santamore, S. Chien, L. Gray Jr, and R. Dowling Chemoreflexes: An Experimental Study Arch Surg, May 1, 2000; 135(5): 577 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Bridges Myocardial laser revascularization: the controversy and the data Ann. Thorac. Surg., February 1, 2000; 69(2): 655 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lauer, U. Junghans, F. Stahl, R. Kluge, S. N. Oesterle, and G. Schuler Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1663 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rimoldi, S. M. Burns, S. D. Rosen, T. E. Wistow, P. M. Schofield, G. Taylor, and P. G. Camici Measurement of Myocardial Blood Flow With Positron Emission Tomography Before and After Transmyocardial Laser Revascularization Circulation, November 9, 1999; 100(90002): II-134 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Chu, J.-q. Kuang, A. McGinn, A. Giaid, S. Korkola, and R. C. -J. Chiu ANGIOGENIC RESPONSE INDUCED BY MECHANICAL TRANSMYOCARDIAL REVASCULARIZATION J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 849 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.C. Hughes, B. H. Annex, B. Yin, A. M. Pippen, P. Lin, A. P. Kypson, K. G. Peters, J. E. Lowe, and K. P. Landolfo Transmyocardial laser revascularization limits in vivo adenoviral-mediated gene transfer in porcine myocardium Cardiovasc Res, October 1, 1999; 44(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. Chu, A. Giaid, J.-q. Kuang, A. N. McGinn, C. M. Li, M. P. Pelletier, and R. C.-J. Chiu Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures Ann. Thorac. Surg., August 1, 1999; 68(2): 301 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Hirsch, G. W. Thompson, R. C. Arora, K. J. Hirsch, J. A. Sullivan, and J. A. Armour Transmyocardial laser revascularization does not denervate the canine heart Ann. Thorac. Surg., August 1, 1999; 68(2): 460 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Eckstein, A. M. Scheule, U. Vogel, S. T. Schmid, S. Miller, M. J. Jurmann, and G. Ziemer Transmyocardial laser revascularization in the acute ischaemic heart: no improvement of acute myocardial perfusion or prevention of myocardial infarction Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 702 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Diegeler, J. Schneider, B. Lauer, F.W. Mohr, and R. Kluge Transmyocardial laser revascularization using the Holium-YAG laser for treatment of end stage coronary artery disease Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Topol and P. W. Serruys Frontiers in Interventional Cardiology Circulation, October 27, 1998; 98(17): 1802 - 1820. [Full Text] [PDF]
|
|
|
|
|
|
T. Kohmoto, C. M. DeRosa, N. Yamamoto, P. E. Fisher, P. Failey, C. R. Smith, and D. Burkhoff Evidence of Vascular Growth Associated With Laser Treatment of Normal Canine Myocardium Ann. Thorac. Surg., May 1, 1998; 65(5): 1360 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. deGuzman and L. H. Cohn Reply Ann. Thorac. Surg., May 1, 1998; 65(5): 1511 - 1511. [Full Text] [PDF]
|
|
|
|
|
|
A. Milano, S. Pratali, G. Tartarini, R. Mariotti, M. De Carlo, G. Paterni, G. Boni, and U. Bortolotti Early Results of Transmyocardial Revascularization With a Holmium Laser Ann. Thorac. Surg., March 1, 1998; 65(3): 700 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Kwong, G. K. Kanellopoulos, J. C. Nickols, S. M. Pogwizd, J. E. Saffitz, R. B. Schuessler, and T. M. Sundt III TRANSMYOCARDIAL LASER TREATMENT DENERVATES CANINE MYOCARDIUM J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 883 - 890. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
